April 27, 2017 / 5:19 PM / 4 months ago

BRIEF-U.S. FDA says granted approval of Brineura to Biomarin Pharmaceutical

April 27 (Reuters) - U.S. Food and Drug Administration :

* FDA approves first treatment for a form of batten disease

* Granted approval of Brineura to Biomarin Pharmaceutical Inc

* Will require Biomarin Pharmaceutical Inc to further evaluate the safety of Brineura in CLN2 patients below the age of 2 years Source text : (bit.ly/2oQ3x55) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below